Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

Cardiovascular events in patients undergoing hip fracture surgery treated with remote ischaemic preconditioning: 1-year follow-up of a randomised clinical trial

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The Cost Implications of Dabigatran in Patients with Myocardial Injury After Non-Cardiac Surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Dangers of hyperoxia

    Research output: Contribution to journalReviewResearchpeer-review

  4. Letter the editor: serious methodological concerns about a recently published meta-analysis on oxygen therapy

    Research output: Contribution to journalLetterResearchpeer-review

  • S Ekeloef
  • S Koyuncu
  • J Holst-Knudsen
  • O Gundel
  • C S Meyhoff
  • M Homilius
  • M Stilling
  • P Ekeloef
  • A M B Münster
  • O Mathiesen
  • I Gögenur
View graph of relations

Remote ischaemic preconditioning reduces the risk of myocardial injury within 4 days of hip fracture surgery. We aimed to investigate the effect of remote ischaemic preconditioning on the incidence of major adverse cardiovascular events 1 year after hip fracture surgery. We performed a phase-2, multicentre, randomised, observer-blinded, clinical trial between February 2015 and September 2017. We studied patients aged ≥ 45 years with a hip fracture and a minimum of one cardiovascular risk factor. Patients were allocated randomly to remote ischaemic preconditioning applied just before surgery or no treatment (control group). Remote ischaemic preconditioning was performed on the upper arm with a tourniquet in four cycles of 5 min ischaemia and 5 min reperfusion. Primary outcome was the occurrence of major adverse cardiovascular events within 1 year of surgery. A total of 316 patients were allocated randomly to the remote ischaemic preconditioning group and 309 patients to the control group. Major adverse cardiovascular events occurred in 43 patients (13.6%) in the remote ischaemic preconditioning group compared with 51 patients (16.5%) in the control group (adjusted hazard ratio (95%CI) 0.83 (0.55-1.25); p = 0.37). Fewer patients in the remote ischaemic preconditioning group had a myocardial infarction (11 (3.5%) vs. 22 (7.1%); hazard ratio (95%CI) 0.48 (CI 0.23-1.00); p = 0.04). Remote ischaemic preconditioning did not reduce the occurrence of major adverse cardiovascular events within 1 year of hip fracture surgery. The effect of remote ischaemic preconditioning on clinical cardiovascular outcomes in non-cardiac surgery needs confirmation in appropriately powered randomised clinical trials.

Original languageEnglish
JournalAnaesthesia
Volume76
Issue number8
Pages (from-to)1042-1050
Number of pages9
ISSN0003-2409
DOIs
Publication statusPublished - Aug 2021

    Research areas

  • cardiovascular complication, non-cardiac surgery, remote ischaemic preconditioning

ID: 62355882